Clarus Ventures II, LLC, 10% Owner at ACHILLION PHARMACEUTICALS INC (ACHN), bought 4,875,502 shares at $2.49 ($12.1M) on 2010-08-20, disclosed to the SEC on 2010-08-20.
Open-market purchase of $12.1M ACHN by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| Filing → |
| AERI | SELL | 2014-12-24 | $1.5M | — | Filing → |
| ACHN | SELL | 2010-01-13 | $882K | — | Filing → |